The use of AI without meticulous scrutiny of its training data can inadvertently perpetuate or exacerbate harm to minority groups.

Much of the contemporary discussions on racial representation and minority empowerment have been focused on increased participation in politics, higher education, and the workforce. A facet that warrants increased public scrutiny is the lack of minority representation in randomized clinical trials, which plays a critical role in perpetuating health inequities. Today’s clinical trials fail to represent the rich diversity of this country, which effectively tailor promising treatment options to non-Hispanic whites due to study over-representation.